Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
49,625,327
-
Total 13F shares
-
6,951,728
-
Share change
-
+132,929
-
Total reported value
-
$54,359,000
-
Price per share
-
$7.82
-
Number of holders
-
20
-
Value change
-
+$886,775
-
Number of buys
-
13
-
Number of sells
-
2
Institutional Holders of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) as of Q4 2021
As of 31 Dec 2021 Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,951,728 shares of stock of the company.
Largest 10 holders included FMR LLC, Northpond Ventures, LLC, FRANKLIN RESOURCES INC, Sands Capital Ventures, LLC, VANGUARD GROUP INC, BlackRock Inc., Woodline Partners LP, GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, and STATE STREET CORP.
This table shows 20 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.